Bio-Works Technologies
Bio-Works receives WorkBeads order worth SEK 2.5 million
REG
The customer is a global contract development and manufacturing organization (CDMO) focused on peptide- and oligonucleotide-based therapies.
“The order from a returning global CDMO confirms our strong position in the purification of peptide- and oligonucleotide-based pharmaceuticals. It is a clear sign that Bio-Works delivers solutions that meet the highest standards of quality and performance,” says Lone Carlbom, CEO of Bio-Works.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 15-05-2025 15:02 CET.
| Datum | 2025-05-15, kl 15:02 |
| Källa | Cision |
100% cashback på aktiecourtage! Handla aktier på eToro och få tillbaka 100% av ditt courtage i 3 månader. Hur? Registrera dig här nu direkt för att ta del av erbjudandet.
Cashback är begränsad till högst $100. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.